Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature.
第一作者:
Takahiko,Toyonaga
第一单位:
Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan.
作者:
主题词
肾上腺皮质激素类(Adrenal Cortex Hormones);成年人(Adult);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);抗体, 单克隆(Antibodies, Monoclonal);贝赫切特综合征(Behcet Syndrome);染色体, 人, 8对(Chromosomes, Human, Pair 8);女(雌)性(Female);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肠疾病(Intestinal Diseases);男(雄)性(Male);骨髓增生异常综合征(Myelodysplastic Syndromes);治疗失败(Treatment Failure);三体性(Trisomy)
DOI
10.1159/000355341
PMID
24247154
发布时间
2022-04-19
- 浏览22

Digestion
217-21页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文